Oral immunization with rVSV bivalent vaccine elicits protective immune responses, including ADCC, against both SARS-CoV-2 and Influenza A viruses

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Epidemiology

Medicine

Immunology

Microbiology

Show all topics

DOI

10.1101/2023.07.14.549076

License

CC-BY

Other Formats

PDF